Looking forward to it!
Meanwhile relevant to the current discussion about the wider use of CGMs by those without diabetes or even prediabetes and what the data obtained means … is this past thread:
It is a fun reread I think.
Still the case that we don’t really have a good set of how daily glucose curves are distributed across the population, what “normal” is, let alone how the curve shapes, peaks and valley heights and depths, correlate with outcomes longer term, and then if whatever the correlations may be are causative or each caused by some other factor, like dysfunctional inflammation or excessive unremitting stress. Or other. Or if interventions that result in flatter curves lower any future risks.
I said it in that thread and I will repeat here: it may turn out at some future date that CGMs will give meaningful actionable information for those without diabetes. But the data to do that has not been collected or analyzed yet.